BR0205970A - Modulação favorável da qualidade de vida relacionada à saúde e a qualidade ajustada ao tempo de progressão da doença relacionada à saúde em pacientes com c ncer de próstata - Google Patents
Modulação favorável da qualidade de vida relacionada à saúde e a qualidade ajustada ao tempo de progressão da doença relacionada à saúde em pacientes com c ncer de próstataInfo
- Publication number
- BR0205970A BR0205970A BR0205970-3A BR0205970A BR0205970A BR 0205970 A BR0205970 A BR 0205970A BR 0205970 A BR0205970 A BR 0205970A BR 0205970 A BR0205970 A BR 0205970A
- Authority
- BR
- Brazil
- Prior art keywords
- health
- quality
- life
- time
- progression
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
"MODULAçãO FAVORáVEL DA QUALIDADE DE VIDA RELACIONADA à SAúDE E A QUALIDADE AJUSTADA AO TEMPO DE PROGRESSãO DA DOENçA RELACIONADA à SAúDE EM PACIENTES COM C NCER DE PRóSTATA". Está apresentado na presente invenção um método para a modulação favorável da qualidade de vida relacionada à saúde e a qualidade ajustada ao tempo de progressão da doença relacionada à saúde em um paciente possuindo câncer de próstata e um método para a medição da qualidade ajustada ao tempo de progressão da doença relacionada à saúde.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/832,752 US20030022811A1 (en) | 2001-04-11 | 2001-04-11 | Favorable modulation of health-related quality of life and health-related quality-adjusted time-to-progression of disease in patients with prostate cancer |
US11848602A | 2002-04-08 | 2002-04-08 | |
PCT/US2002/011397 WO2002085351A1 (en) | 2001-04-11 | 2002-04-11 | Favorable modulation of health-related quality of life and health-related quality-adjusted time-to-progression of disease in patients with prostate cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0205970A true BR0205970A (pt) | 2003-09-30 |
Family
ID=26816420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0205970-3A BR0205970A (pt) | 2001-04-11 | 2002-04-11 | Modulação favorável da qualidade de vida relacionada à saúde e a qualidade ajustada ao tempo de progressão da doença relacionada à saúde em pacientes com c ncer de próstata |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1379238A1 (pt) |
JP (1) | JP2005503339A (pt) |
CN (1) | CN1514727A (pt) |
AR (1) | AR033465A1 (pt) |
BR (1) | BR0205970A (pt) |
CA (1) | CA2442591A1 (pt) |
IL (1) | IL158071A0 (pt) |
MX (1) | MXPA03009277A (pt) |
PE (1) | PE20021032A1 (pt) |
WO (1) | WO2002085351A1 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0219660D0 (en) | 2002-08-23 | 2002-10-02 | Astrazeneca Ab | Therapeutic use |
WO2004100991A1 (en) * | 2003-05-15 | 2004-11-25 | Universite Catholique De Louvain | Use of endothelin-1 antagonists for improving cancer therapy |
GB0403744D0 (en) | 2004-02-20 | 2004-03-24 | Astrazeneca Ab | Chemical process |
JP2009537535A (ja) * | 2006-05-15 | 2009-10-29 | エンサイシブ・ファーマシューティカルズ・インコーポレイテッド | エンドセリンアンタゴニストの投与を含む睡眠時無呼吸を治療するための方法および組成物 |
JP2010536880A (ja) | 2007-08-22 | 2010-12-02 | ギリード・コロラド・インコーポレーテッド | 糖尿病の合併症のための療法 |
CN117751099A (zh) * | 2021-08-05 | 2024-03-22 | 中国药科大学 | 酰胺类化合物及其应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1003740A2 (en) * | 1997-08-04 | 2000-05-31 | Abbott Laboratories | Pyrrolidine-3-carboxylic acid derivatives and their use as endothelin antagoists |
-
2002
- 2002-04-11 CA CA002442591A patent/CA2442591A1/en not_active Abandoned
- 2002-04-11 IL IL15807102A patent/IL158071A0/xx unknown
- 2002-04-11 CN CNA028116720A patent/CN1514727A/zh active Pending
- 2002-04-11 PE PE2002000305A patent/PE20021032A1/es not_active Application Discontinuation
- 2002-04-11 JP JP2002582924A patent/JP2005503339A/ja active Pending
- 2002-04-11 BR BR0205970-3A patent/BR0205970A/pt not_active IP Right Cessation
- 2002-04-11 AR ARP020101335A patent/AR033465A1/es not_active Application Discontinuation
- 2002-04-11 EP EP02726727A patent/EP1379238A1/en not_active Ceased
- 2002-04-11 WO PCT/US2002/011397 patent/WO2002085351A1/en not_active Application Discontinuation
- 2002-04-11 MX MXPA03009277A patent/MXPA03009277A/es unknown
Also Published As
Publication number | Publication date |
---|---|
PE20021032A1 (es) | 2002-11-12 |
CA2442591A1 (en) | 2002-10-31 |
EP1379238A1 (en) | 2004-01-14 |
WO2002085351A1 (en) | 2002-10-31 |
IL158071A0 (en) | 2004-03-28 |
CN1514727A (zh) | 2004-07-21 |
MXPA03009277A (es) | 2004-03-10 |
AR033465A1 (es) | 2003-12-17 |
JP2005503339A (ja) | 2005-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1992695T3 (da) | Lectin-transmembran-antigen af type C udtrykt i human prostatacancer og avendelser deraf | |
CY1106285T1 (el) | Χρηση αναστολεων της τυροσινης κινασης του egfr για τη θepαπεια του καρκινου του μαστου | |
AU2001228767A1 (en) | Forceps useful for intrabody guiding and/or positioning of medical instrument | |
DE602004031565D1 (de) | Einstellbares Wirbelsäulenimplantat und Gerät zur postoperativen Einstellung desselben | |
BRPI0411200A (pt) | método de tratamento de cáncer, métodos de tratamento de paciente humano, artigo industrializado e kit de tratamento de cáncer | |
DE69920178D1 (de) | Super-elastische gebogene hohlnadel zur medizinischen verwendung | |
AU2002239491A1 (en) | Methods for the treatment of cancer and other diseases and methods of developing the same | |
DE60320003D1 (de) | Führungsblock zur verwendung in der chirurgie | |
BR0205970A (pt) | Modulação favorável da qualidade de vida relacionada à saúde e a qualidade ajustada ao tempo de progressão da doença relacionada à saúde em pacientes com c ncer de próstata | |
HK1080733A1 (en) | Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a cox-2 inhibitor and a taxol | |
ATE178357T1 (de) | Nachweismethoden für c-raf-1-genes.5 | |
DK0981348T3 (da) | Anvendelse af levobupivacain i pædiatrisk kirurgi | |
AU2002350950A1 (en) | Compounds for imaging alzheimer's disease | |
BR0311146A (pt) | Uso de tibolona e de modulador de receptor de estrogênio seletivo, e, método e kit para o tratamento de um sintoma relacionado com a deficiência de estrogênio em um paciente do sexo feminino | |
BR9810616A (pt) | Inibidores de farnesil transferase em combinação com inibidores de hmg coa redutase para o tratamento do cancer | |
DE60224299D1 (de) | Kombinationsmedikationen mit einem selektiven cyclooxygenase-2-inhibitor | |
PT585801E (pt) | Proteina tipo caderina relacionada com osso e processo para a sua producao | |
AU2003250912A1 (en) | Agents and methods for diagnosis and therapy of cancer and cancer risk assessment | |
BR9406806A (pt) | Instrumento (laringoscópio) para exposiçao da área da garganta de um paciente | |
NO962248D0 (no) | Joderte bifenylderivater og deres diagnostiske anvendelse | |
DE60205911T2 (de) | Teilhydrolysierte Fischgelatine enthaltende Zubereitungen und deren Verwendung | |
FI962769A (fi) | (E)-2'-deoksi-2'(fluorimetyleeni)sytidiinin monohydraatti | |
UA28112C2 (uk) | Інструмент для з'єднання м'яких біологічних тканин | |
AU2002317169A1 (en) | Use of the indication of the expression of splice variants of gene 21 for the diagnosis and treatment of tumour diseases | |
AU2002342250A1 (en) | Use of casb 7439 for treatment and diagnosis of lung cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A(S) 9A ANUIDADE(S) |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2103 DE 26/04/2011. |